GalanthaminoneCholinesterase(AChE) inhibitor CAS# 510-77-0 |
Related Products
- A-867744
Catalog No.:BCC1324
CAS No.:1000279-69-5
- Rocuronium Bromide
Catalog No.:BCC1068
CAS No.:119302-91-9
- Rivastigmine
Catalog No.:BCC1900
CAS No.:123441-03-2
- Rocuronium
Catalog No.:BCC1906
CAS No.:143558-00-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 510-77-0 | SDF | Download SDF |
| PubChem ID | 441596 | Appearance | Cryst. |
| Formula | C17H19NO3 | M.Wt | 285.3 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Synonyms | (-)-Narwedine; Narwedin | ||
| Solubility | DMSO : 10 mg/mL (35.05 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) | ||
| SMILES | CN1CCC23C=CC(=O)CC2OC4=C(C=CC(=C34)C1)OC | ||
| Standard InChIKey | QENVUHCAYXAROT-RHSMWYFYSA-N | ||
| Standard InChI | InChI=1S/C17H19NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,14H,7-10H2,1-2H3/t14-,17-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
The bulbs of Lycoris radiata
| Description | 1. Galanthaminone (Narwedin) is a competitive and reversible cholinesterase (AChE) inhibitor; is used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments. |
| Targets | AChR | IL Receptor |
Galanthaminone Dilution Calculator
Galanthaminone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.5051 mL | 17.5254 mL | 35.0508 mL | 70.1016 mL | 87.6271 mL |
| 5 mM | 0.701 mL | 3.5051 mL | 7.0102 mL | 14.0203 mL | 17.5254 mL |
| 10 mM | 0.3505 mL | 1.7525 mL | 3.5051 mL | 7.0102 mL | 8.7627 mL |
| 50 mM | 0.0701 mL | 0.3505 mL | 0.701 mL | 1.402 mL | 1.7525 mL |
| 100 mM | 0.0351 mL | 0.1753 mL | 0.3505 mL | 0.701 mL | 0.8763 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Galantamine(Narwedin) is a competitive and reversible cholinesterase(AChE) inhibitor; is used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments.
Featured Products
- AMI-193
Catalog No.:BCC6679
CAS No.:510-74-7
- Echinocystic acid
Catalog No.:BCN5628
CAS No.:510-30-5
- Belladonnine
Catalog No.:BCN1892
CAS No.:510-25-8
- Voacangine
Catalog No.:BCN3224
CAS No.:510-22-5
- Trachelanthine
Catalog No.:BCN2042
CAS No.:510-19-0
- Tetramethylammonium
Catalog No.:BCN1816
CAS No.:51-92-3
- (2-Acetoxyethyl)trimethylammonium
Catalog No.:BCN1743
CAS No.:51-84-3
- Carbamoylcholine chloride
Catalog No.:BCC7492
CAS No.:51-83-2
- Tyramine
Catalog No.:BCN6776
CAS No.:51-67-2
- 4'-Methoxyacetanilide
Catalog No.:BCC8711
CAS No.:51-66-1
- D-Amphetamine sulfate
Catalog No.:BCC5942
CAS No.:51-63-8
- Homatropine Bromide
Catalog No.:BCC4570
CAS No.:51-56-9
New Products
- Minecoside
Catalog No.:BCN5627
CAS No.:51005-44-8
- 6''-O-Malonylgenistin
Catalog No.:BCN2772
CAS No.:51011-05-3
- Isocorynoxeine
Catalog No.:BCN5003
CAS No.:51014-29-0
- Demethylcephalotaxinone
Catalog No.:BCN7070
CAS No.:51020-45-2
- (+)-Licarin A
Catalog No.:BCC9008
CAS No.:51020-86-1
- (-)-Licarin B
Catalog No.:BCN1241
CAS No.:51020-87-2
- Salbutamol Sulfate
Catalog No.:BCC4338
CAS No.:51022-70-9
- Acipimox
Catalog No.:BCC4884
CAS No.:51037-30-0
- Flurbiprofen
Catalog No.:BCC3781
CAS No.:5104-49-4
- Z-GABA-OH,Z-gama-Abu-OH
Catalog No.:BCC2644
CAS No.:5105-78-2
- alpha-Lipomycin
Catalog No.:BCN1842
CAS No.:51053-40-8
- Wogonoside
Catalog No.:BCN1200
CAS No.:51059-44-0
Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition.[Pubmed:1914378]
Clin Pharmacol Ther. 1991 Oct;50(4):420-8.
Measurements were done to determine the plasma concentrations of galanthamine and two of its metabolites, as well as the corresponding inhibition of acetylcholinesterase activity in erythrocytes after applying 5 and 10 mg galanthamine hydrobromide as a constant-rate intravenous infusion for 30 minutes and single oral doses of 10 mg in eight healthy male volunteers. The data obtained revealed first-order pharmacokinetics, complete oral bioavailability, and a mean terminal half-life of 5.68 hours (95% confidence interval, 5.17 to 6.25 hours). Renal clearance accounted for only 25% of the total plasma clearance (CL = 0.34 L.kg-1.hr-1). Only negligible quantities of the putative metabolites, epigalanthamine and Galanthaminone, were detected in blood and urine. The inhibition of acetylcholinesterase activity was closely correlated with the pharmacokinetics of galanthamine, a median maximal value of 53% being achieved by applying 10 mg galanthamine intravenously. Analysis of in vitro and ex vivo concentration responses revealed no differences, indicating that no metabolites of galanthamine exert additional inhibition of acetylcholinesterase activity.
Galanthaminone (Narwedin) is a competitive and reversible cholinesterase (AChE) inhibitor; is used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments.
Galanthaminone,510-77-0,(-)-Narwedine; Narwedin,Natural Products,AChE, buy Galanthaminone , Galanthaminone supplier , purchase Galanthaminone , Galanthaminone cost , Galanthaminone manufacturer , order Galanthaminone , high purity Galanthaminone
